Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "SWOG S1929 Phase II Randomized Study - Maintenance Atezo vs. Atezo + Talazoparib in Patients With SLFN11+ ES-SCLC"

54 views
July 3, 2023
Comments 0
Login to view comments. Click here to Login